skip to main content
Show Results with:

2861 Prospective multicenter phase II study of the anti-EGFR (epidermal growth factor receptor) antibody panitumumab (P) in patients with platinum pre-treated, advanced head and neck squamous cell cancer (HNSCC)

Siano, M. et al.

European journal of cancer. Volume 51: (2015) Supplement 3; pp S576-S577 -- Elsevier

Online access

Searching Remote Databases, Please Wait